Generation of organoid models of breast and ovarian cancer.

  • Research type

    Research Study

  • Full title

    Generation of organoids and ex vivo tissue explants from breast and ovarian cancer tissue to develop pre-clinical models of cancer.

  • IRAS ID

    248715

  • Contact name

    Melanie Flint

  • Contact email

    M.flint@brighton.ac.uk

  • Sponsor organisation

    University of Brighton

  • Duration of Study in the UK

    5 years, 0 months, 1 days

  • Research summary

    The goal of this project is to source breast and ovarian cancer tissue to develop cancer organoids and tissue explants so that we can study the effects of stress hormones and oxidative stress on cancer immune biology. To do this we plan to develop a 3 dimensional organoid cell culture model of human cancer cells and grow tumour tissue on sponges for purposes of examining how the organoid and tissue explants responds to stress hormones such as cortisol, norepinephrine and oxidative stress. The study has been designed to use anonymised, surplus surgical tumour tissue and an extra blood taken at the same time it is taken routinely as part of a clinical procedure to minimise the impact to the patients.

  • REC name

    South Central - Berkshire B Research Ethics Committee

  • REC reference

    18/SC/0690

  • Date of REC Opinion

    4 Jan 2019

  • REC opinion

    Favourable Opinion